Patents Assigned to smartDNA Pty Ltd
  • Patent number: 11447811
    Abstract: The present disclosure relates to methods of diagnosing a dysbiosis in a subject, methods of determining a suitable treatment, and methods of treating a dysbiosis. In some aspects, the present disclosure relates to diagnosing or determining a subtype of irritable bowel syndrome (IBS).
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: September 20, 2022
    Assignee: smartDNA Pty Ltd
    Inventor: Margaret Smith